PMSNF (Proteome Sciences) Other Stockholders Equity: $20.83 Mil (As of Dec. 2025)


What is Proteome Sciences Other Stockholders Equity?

Proteome Sciences PMSNF Other Stockholders Equity is $20.83 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Proteome Sciences's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $20.83 Mil.

Proteome Sciences's quarterly Other Stockholders Equity increased from Dec. 2024 ($19.49 Mil) to Jun. 2025 ($21.02 Mil) but then declined from Jun. 2025 ($21.02 Mil) to Dec. 2025 ($20.83 Mil).

Proteome Sciences's annual Other Stockholders Equity declined from Dec. 2023 ($19.57 Mil) to Dec. 2024 ($19.49 Mil) but then increased from Dec. 2024 ($19.49 Mil) to Dec. 2025 ($20.83 Mil).

Proteome Sciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Other Stockholders Equity Chart

Proteome Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.71 18.61 19.57 19.49 20.83

Proteome Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.57 19.68 19.49 21.02 20.83

Proteome Sciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $20.83 Mil mean?
Proteome Sciences (PMSNF) has a Other Stockholders Equity of $20.83 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Proteome Sciences and its competitors.
Is Proteome Sciences' Other Stockholders Equity too high?
Proteome Sciences' current Other Stockholders Equity is $20.83 Mil.
How does Proteome Sciences' Other Stockholders Equity compare to TMO and DHR?
Proteome Sciences' Other Stockholders Equity of $20.83 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Proteome Sciences and its competitors. Proteome Sciences's current Other Stockholders Equity is $20.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current Other Stockholders Equity of $20.83 Mil. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current Other Stockholders Equity is $20.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Other Stockholders Equity is $20.83 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRMl:UKPRM:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.